Effects of sodium-glucose co-transporter2(SGLT2) inhibitors on left ventricular systolic and/or diastolic dysfunction in Japanese type2 diabetes
Not Applicable
Recruiting
- Conditions
- Type2 diabetic patients with systolic and/or diastolic dysfunction
- Registration Number
- JPRN-UMIN000025841
- Lead Sponsor
- Kanagawa Cardiovascular and Respiratory Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1patients with type1 diabetes 2Patients with severe infection, perioperative, severe ketosis, severeinjury 3Patients with mild renal dysfunction(sCr>1.5mg/dl) 4Patients with severe heart failure(NYHA class 4) 5Patients with serious hepatic dysfunction 6Patients with mild MR 7Patients with atrial fibrillation 8Patients with risk of dehydration 9Patients with malignancy 10Patients with malnutrition, stavation 11Patients who are pregnant, breastfeeding or may become pregnant 12Patients taking SGLT2I 13Patients who considered not eligible for the study by the attending doctor due to other reasons
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method